Cochrane Abstracts
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Versus First-generation Antipsychotics for the Treatment of Schizophrenia and Other Psychotic Disorders: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436201/all/Haloperidol_versus_first_generation_antipsychotics_for_the_treatment_of_schizophrenia_and_other_psychotic_disorders:_Cochrane_systematic_review. Accessed 05 February 2023.
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436201/all/Haloperidol_versus_first_generation_antipsychotics_for_the_treatment_of_schizophrenia_and_other_psychotic_disorders:_Cochrane_systematic_review. Accessed February 5, 2023.
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436201/all/Haloperidol_versus_first_generation_antipsychotics_for_the_treatment_of_schizophrenia_and_other_psychotic_disorders:_Cochrane_systematic_review
Haloperidol Versus First-generation Antipsychotics for the Treatment of Schizophrenia and Other Psychotic Disorders: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 February 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436201/all/Haloperidol_versus_first_generation_antipsychotics_for_the_treatment_of_schizophrenia_and_other_psychotic_disorders:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review
ID - 436201
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436201/all/Haloperidol_versus_first_generation_antipsychotics_for_the_treatment_of_schizophrenia_and_other_psychotic_disorders:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
